Bortezomib-bortenat (2 mg & 3.5 mg)

NATCO PHARMA LIMITED (INDIA)

“Bortezomib” is the Drug / Molecule content in “Bortenat”. Bortezomib is a reversible inhibitor of the chymotrypsin-like activity of proteasome. It prevents targeted proteolysis that affects multiple signaling cascades responsible for normal homeostatic functions within the cell, leading to cell death.

Category:

Indication

Bortenat is used for the treatment of Multiple Myeloma. Also used for Mantle Cell Lymphoma

Note

Precaution

  • Bortenat is a prescription drug and should be used under proper medical guidance and advice.
  • Contraindicated in in patients with hypersensitivity to Bortezomib, boron or mannitol.

Related products